Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)

NCT00500383 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00500383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00500383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
July 31, 2015
Enrollment
372 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer